ELOXX PHARMACEUTICALS, INC. Public Float
ELOXX PHARMACEUTICALS, INC. (ELOX) had Public Float of $330.00 thousand as of 2025-06-30, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-17
- 2025-06-30: Entity Public Float $330.00K.
- 2022-06-30: Entity Public Float $16.65M.
- 2021-06-30: Entity Public Float $137.40M.
- 2020-06-30: Entity Public Float $82.83M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $330.00K 10-K · filed 2026-03-17 |
| 2022-06-30 | $16.65M 10-K · filed 2023-03-31 |
| 2021-06-30 | $137.40M 10-K · filed 2022-03-30 |
| 2020-06-30 | $82.83M 10-K · filed 2021-03-12 |
| 2019-06-28 | $268.97M 10-K · filed 2020-03-06 |
| 2018-06-30 | $247.53M 10-K · filed 2019-03-14 |
| 2017-06-30 | $7.09M 10-K · filed 2018-03-16 |
| 2016-12-31 | $2.52M 10-K · filed 2017-10-13 |
| 2015-12-31 | $6.81M 10-K · filed 2016-10-13 |
| 2014-12-31 | $9.10M 10-K · filed 2015-10-09 |
| 2013-12-31 | $28.66M 10-K · filed 2014-09-29 |
| 2012-12-31 | $15.72M 10-K · filed 2013-09-11 |
| 2011-12-31 | $17.81M 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |